Estro Control 3.0
Natural health product licensed in Canada
- Other names
- Estro Health / Estro Santé
- Licence holder
- ATP ATHLÉTIQUE ET THÉRAPEUTIQUE PHARMA INC. ou ATP ATHLETIC AND THERAPEUTIC PHARMA INC.
- NPN or DIN-HM
- 80078852
- Status
- Active licence
- Licence date
- 4 July 2017
- Revision date
- 18 September 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| trans-Resvératrol Source : Resvératrol | 80 milligramme | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 milligramme Potency : 9 milligramme Caffeine | 100 milligramme | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Potency : 45 % Epigallocatechin 3-gallate | Not specified | Not calculated |
| 3,3'-méthylènebis-1H-indole Source : 3,3'-diindolylméthane | 100 milligramme | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 600 milligramme Potency : 45 % Curcuminoids | 60 milligramme | Not calculated |
| Sel de calcium acide d-Glucarique (1:1) Source : Saccharate de calcium | 200 milligramme | Not calculated |
| Brassica oleracea var. italica Source : Brassica oleracea var. italica - germe Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2,000 milligramme Potency : 0.1 % Sulforaphane | 100 milligramme | Not calculated |
Non-medicinal ingredients
Acide stéarique, Poudre d'enveloppes d'Oryza sativa (Riz), Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Helps to support/promote healthy estrogen metabolism/balance. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult your health care practitioner prior to use if you are attempting to conceive. Consult a health care practitioner prior to use if you have or are pre-disposed to cancer. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid. Consult a health care practitioner prior to use if you have an iron deficiency. If you are taking any medications or natural health products, consult a health care practitioner prior to use. If you have a liver disorder or symptoms of low estrogen (such as joint pain, mood changes, changes in libido, hot flashes, night sweats, vaginal dryness or irregular menstruations), consult a healthcare practitioner prior to use. To exclude the diagnosis of a serious cause of hormonal imbalance, consult a healthcare practitioner prior to use. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner.
- Contre-indications
Do not use if you are pregnant or breastfeeding. Discontinue use if you experience joint pain or hot flashes. If you develop liver-related symptoms (e.g. yellowing of the eyes and/or skin, dark urine, abdominal pain, jaundice) or symptoms of low estrogen, discontinue use and consult a health care practitioner. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally).
Source
Official Health Canada record, licence 80078852
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging